Sharon Shacham
2016
In 2016, Sharon Shacham earned a total compensation of $1.4M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 69% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,000 |
|---|---|
| Option Awards | $758,523 |
| Salary | $415,000 |
| Other | $11,260 |
| Total | $1,350,783 |
Shacham received $758.5K in option awards, accounting for 56% of the total pay in 2016.
Shacham also received $166K in non-equity incentive plan, $415K in salary and $11.3K in other compensation.
Rankings
In 2016, Sharon Shacham's compensation ranked 6,771st out of 14,075 executives tracked by ExecPay. In other words, Shacham earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,771 out of 14,075 | 52nd |
Division Manufacturing | 2,528 out of 5,486 | 54th |
Major group Chemicals And Allied Products | 823 out of 1,900 | 57th |
Industry group Drugs | 632 out of 1,543 | 59th |
Industry Pharmaceutical Preparations | 498 out of 1,173 | 58th |
Source: SEC filing on April 28, 2017.
Shacham's colleagues
We found three more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2016.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019